Since the early 2000s, supplementation of fish oil has significantly increased in part for the touted antidepressant effects. Many studies have found correlations between people who eat diets high in fish and lower incidences of depression. This has lead many Americans and others to look for ways to possibly mimic this antidepressant effect. One shortcut …
Many people going through withdrawal from various psychotropic drugs like antidepressants often have a difficult time distinguishing “withdrawal symptoms” from “returning mental illness.” It is generally difficult to distinguish withdrawal from the original illness due to the fact that there is generally some overlap. Withdrawal is capable of producing a variety of symptoms including severe …
Brintellix (Vortioxetine) is considered an atypical antidepressant that was co-developed by pharmaceutical companies Lundbeck and Takeda. Most consider Brintellix to be a new antidepressant as of 2014 due to the fact that it was approved by the FDA in September of 2013. In clinical trials, it proved to demonstrate substantial efficacy for the treatment of …
Most people are aware of the recent tragedy involving well-known actor and comedic legend Robin Williams. Although he was an extremely talented actor with a brilliant comedic talent, he commit suicide on August 11, 2014. This sent most of his close family members, friends, celebrities, and even the general public into shock. Most people were …
The quest to come up with a superior antidepressant is in full effect among biotech and pharmaceutical companies. Although there are some companies that are still tweaking various formulations of serotonergic, noradrenergic, and dopaminergic substances (e.g. triple reuptake inhibitors) others are thinking outside the box. Based on current trends, the next decade or two of …
Scientists and mental health researchers have long been collecting evidence to discover what causes depression. Their goal is to find a specific neurotransmitter or system that could be targeted to develop a new class of antidepressant medication that would be more effective for the masses, result in less side effects, and be considered safe. While …
A new antidepressant chemically named “GLYX-13” was developed by the biotech company Naurex for individuals with treatment-resistant depression. It is currently in clinical trials as an antidepressant augmentation strategy, meaning it is used as an add-on to already approved treatments. However, most evidence would suggest that it works extremely well as a standalone treatment option. …